Hormone Paris

Hormone Paris is a French niche perfume house founded in Paris in 2020 [1]. It describes itself as a "functional fragrance house," designing scents around the science of how smell interacts with the brain rather than around conventional perfume themes. The company is the registered trading name of The Nichessence S.A.S. [2], and it positions its work at the intersection of fine perfumery and contemporary research into olfaction and emotion.

The brand's central idea is reflected in its name. According to the company, the word hormone derives from the ancient Greek hormon, "to set in motion" — the internal signal that precedes action, desire and emotion. Its stated mission is "to explore how chemistry sets feeling in motion," and it is careful to add that this is done "not by putting hormones in a bottle, but by capturing what they make us feel."

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

Hormone Paris was established in Paris in 2020 as a functional fragrance house [1]. Its founders are not publicly named on the brand's own materials, which identify only the legal entity, The Nichessence S.A.S. The fragrances themselves were developed in collaboration with perfumers, among them Shadi Samra and Kévin Mathys, who are credited with specific compositions.

From the outset, the house framed perfume as something to be navigated by intended effect rather than by traditional scent family. Its tagline, "Fragrance, indexed by effect," summarises an approach the brand sums up as "Inspired by neurochemistry. Interpreted through scent." Each fragrance is grouped by an emotional direction such as calming, focusing or strengthening.

Hormone Paris presents itself as a brand built on two commitments: scientific grounding and transparency. The company says it draws on "published research in aromachology, sensory neuroscience, and psychophysiology" to inform each composition, citing the way smell reaches the brain's limbic system — the amygdala and hippocampus — more directly than the other senses. It distinguishes this approach from aromatherapy, describing itself as grounded in contemporary research rather than traditional aromatherapy frameworks.

The house is also explicit about the limits of those claims. It notes that the studies it references were conducted under controlled conditions and "do not describe what you will experience when you wear it," and it states plainly that its products are cosmetics whose effects may vary by individual. The fragrance names, it adds, are conceptual: the perfumes contain no hormones, neurotransmitters or biological compounds.

Transparency is framed as foundational. The brand publishes, for each fragrance, full ingredient lists rather than the abbreviated INCI declaration, along with quantified allergen data, safety documentation and compliance certificates, accessible through a dedicated transparency page reachable by a QR code on the packaging. It states that all formulas are certified to IFRA's 51st Amendment standards [3], and that it complies with EU Cosmetics Regulation 1223/2009.

The brand's perfumes are organised into collections, the principal one being the "This is Not Neuro Compounds" line of eight fragrances, each tied to an emotional state. Products are sold mainly as 100 ml parfum, alongside all-over sprays and a discovery set of sample vials.

Hormone Paris originally named its fragrances directly after hormones and related compounds — among them Serotonin, Dopamine, Oxytocin and Adrenaline. These were later renamed under a "This is Not [hormone]" system, so that the same compositions now appear as titles such as This is Not GABA, described by the brand as a bestseller, and This is Not Caffeine [4]. The company states that while names and packaging changed, the underlying formulas did not. Later additions include This is Not Testosterone, introduced as an expansion of the Neuro Compounds range.

All fragrances are made in France [3]. The brand's pricing places it in the luxury tier, with its 100 ml parfums listed at 200 euros.

After its 2020 founding, Hormone Paris built its presence largely through niche-perfumery trade events and a widening set of retail partners. It introduced This is Not Testosterone at the Esxence fair in Milan in 2024 [5]. At Esxence the following year, the house publicly unveiled a rebrand, presenting a refined visual identity and the renamed fragrance system [6].

Through 2024 and 2025 the brand entered a number of markets via selected retailers, including Germany (Parfumerie Becker) and Poland, with launch events also recorded in Kazakhstan and Ukraine. In 2025 it presented This is Not Caffeine at Galeries Lafayette in Dubai during the store's Beauty and Candy Week [7].

In March 2026, Hormone Paris received the Innovation Award at Snouf, a niche-perfumery exhibition held in Rimini, Italy, where it showed its full lineup [8]. The award is reported by the brand and corresponds to the house's listing in the Snouf 2026 catalogue.

Hormone Paris sells through its official website and a network of selected authorised retail partners worldwide, and it operates multiple logistics hubs to fulfil international orders. The company also states that it offers wholesale and distribution partnerships.

The brand is active. Its most recent recorded activity is its appearance and Innovation Award at Snouf in March 2026, after which its website announced a forthcoming event in Milan. Distribution spans several European and Middle Eastern markets through direct sales and niche retailers.